Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL840554 | 0.93 | CHRNA7 (0.33) | CHRNA7 | |
| SCHEMBL104677 | 0.86 | — | — | |
| SCHEMBL840178 | 0.86 | CHRNA7 (0.42) | CHRNA7SIGMAR1 | |
| SCHEMBL840162 | 0.86 | CHRNA7 (0.36) | CHRNA7 | |
| SCHEMBL1093168 | 0.86 | — | — | |
| SCHEMBL13290565 | 0.86 | CHRNA7 (0.42) | CHRNA7SIGMAR1 | |
| SCHEMBL9322170 | 0.83 | ALDH1A1 (0.30) | — | |
| SCHEMBL24435951 | 0.83 | CHRNA7 (0.40) | CHRNA7SIGMAR1 | |
| SCHEMBL18157902 | 0.83 | CHRNA7 (0.35) | CHRNA7 | |
| SCHEMBL840810 | 0.83 | CHRNA7 (0.40) | CHRNA7SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023220129-A1 | BENZOYPARAZINE PYRAZINES ANE THEIR USES | FOGHORN THERAPEUTICS INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| US-11712485-B2 | Triazine based radiopharmaceuticals and radioimaging agents | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2023-08-01 | — | — | US | disclosed |
| US-11713344-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2023-08-01 | — | — | US | disclosed |
| US-11713344-B2 | Acylated oxyntomodulin peptide analog | DONG-A ST CO., LTD. (KR) | 2023-08-01 | — | — | US | disclosed |
| WO-2023116835-A1 | MULTI-PROTEIN DEGRADATION AGENT HAVING IMIDE SKELETON | 苏州开拓药业股份有限公司 | 2023-06-29 | — | — | WO | disclosed |
| US-20220119473-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | DONG-A ST CO., LTD. (KR) | 2022-04-21 | — | — | US | disclosed |
| EP-2444438-B1 | POLYMERIZABLE COMPOSITION, RESIN MOLDED BODY, AND LAMINATE | ZEON CORP (JP) | 2020-03-18 | — | — | EP | disclosed |
| WO-2019238629-A1 | PYRIDINYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2019-12-19 | — | — | WO | disclosed |
| WO-2019238616-A1 | NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2019-12-19 | — | — | WO | disclosed |
| EP-2977388-B1 | COPOLYMER RUBBER CONTAINING NITRILE GROUP, CROSSLINKABLE RUBBER COMPOSITION, AND RUBBER CROSSLINKED PRODUCT | ZEON CORP (JP) | 2019-09-04 | — | — | EP | disclosed |
| US-20090030014-A1 | Indole Derivative Having Pgd2 Receptor Antagonist Activity | SHIONOGI & CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-2017308-A1 | OXYGEN-ABSORBING RESIN COMPOSITION | Kuraray Co., Ltd. (JP) | 2009-01-21 | — | — | EP | disclosed |
| US-7465773-B2 | Polymerizable composition and formed article using the same | ZEON CORPORATION (JP) | 2008-12-16 | — | — | US | disclosed |
| US-7381782-B2 | Polymerizable composition and molded articles produced by using the same | ZEON CORPORATION (JP) | 2008-06-03 | — | — | US | disclosed |
| US-20060258828-A1 | Polymerizable composition and molded articles produced by using the same | ZEON CORPORATION (JP) | 2006-11-16 | — | — | US | disclosed |
| US-20060211809-A1 | Polymerizable composition and formed article using the same | ZEON CORPORATION (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1655321-A1 | POLYMERIZABLE COMPOSITIONS AND MOLDED ARTICLES PRODUCED BY USING THE SAME | Zeon Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
| EP-1652885-A1 | POLYMERIZABLE COMPOSITION AND FORMED ARTICLE USING THE SAME | Zeon Corporation (JP) | 2006-05-03 | — | — | EP | disclosed |
| EP-1640153-A1 | MULTILAYER BODY AND METHOD FOR PRODUCING SAME | Zeon Corporation (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20050014916-A1 | Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst | ZEON CORPORATION (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11712485-B2 | Triazine based radiopharmaceuticals and radioimaging agents | PSMA2, PSMA5, PSMA1 | CHRNA7 4477/4885SIGMAR1 2691/4885 |
| US-11713344-B2 | Acylated oxyntomodulin peptide analog | GLP1R, GIPR, GPR119 | CHRNA7 1279/4885SIGMAR1 787/4885 |
| US-20220119473-A1 | ACYLATED OXYNTOMODULIN PEPTIDE ANALOG | GLP1R, GIPR, GPR119 | CHRNA7 1279/4885SIGMAR1 787/4885 |
| US-20050014916-A1 | Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst | POR, CAD, HRH1 | CHRNA7 2099/4885SIGMAR1 3082/4885 |
| US-20090030014-A1 | Indole Derivative Having Pgd2 Receptor Antagonist Activity | HRH2, PTGDR, CNR2 | CHRNA7 640/4885SIGMAR1 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.